Opinion

Guest Opinion: Why are people complaining about innovative COVID treatments?

By Peter J. Pits Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. ... Read more

9 hours ago by Guest Columnist.

Guest Opinion: Civility before, during and after election day

By Johnathan Hladik Discussion and debate has always been a part of rural America. From coffee shops to the local co-op, rural residents aren’t afraid ... Read more

14 hours ago by Guest Columnist.

Letter to the Editor: Reader says Judge ‘can help us do better’

To the Editor: I’m a small business owner and healthcare advocate with extensive experience as a caregiver, and I support Tess Judge. Why? Bob Steinburg, ... Read more

14 hours ago by Letters to the Editor.

One on One: President Trump and Nicholas Sparks’ latest book

By D.G. Martin What do President Donald Trump and the lead character of Nicholas Sparks’ latest book have in common? Hint: Walter Reed Medical Center. ... Read more

3 days ago by Guest Columnist.

Memories and Musings: Window washer blues

By Gene Gallelli It would take hours, even days, to list the irritations visited upon a car owner. The gas guzzler could be sitting quietly ... Read more

6 days ago by Guest Columnist.

Guest Opinion: A coronavirus vaccine doesn’t mean the pandemic is over

By Purushottam Meena Dr. Anthony Fauci thinks that drug companies may develop a COVID-19 vaccine before year’s end. But that doesn’t mean the pandemic will ... Read more